Case Report
BibTex RIS Cite

Serebral Enfarktla Seyreden Çocukluk Çağı Santral Sinir Sistemi Tüberkülozu Olgusu

Year 2020, Volume: 4 Issue: 1, 51 - 55, 30.04.2020
https://doi.org/10.34084/bshr.719006

Abstract

Çocuklarda santral sinir sistemi tüberkülozu oldukça nadir görülmekle birlikte tüberküloza bağlı ölüm ve uzun dönem sekellerin en sık sebebidir. BCG aşısının hastaları tüberküloz menenjitinden yüksek oranda koruduğu bilinmekle birlikte yaş ile birlikte koruyuculuğu azalmaktadır. Hastalıkta etken her zaman gösterilememekte, tanı ancak hikâye, fizik muayene, laboratuvar ve görüntüleme yöntemlerinin birlikte değerlendirilmesi ile konulabilmektedir. Hastalığın prognozu ise erken tanı ve anti-tüberküloz tedavinin başlanma zamanıyla doğrudan ilişkilidir. Serebral enfarkt ile seyreden santral sinir sistemi tüberkülozu vakası erken tanı ve tedavinin vurgulanması amacıyla sunulmuştur.

References

  • 1. Zumla A, George A, Sharma V, et al. The WHO 2014 global tuberculosis report–further to go. Lancet Glob Health 2015; 3(1): e10–2.
  • 2. Türkiyede Verem Savaş Raporu 2018. https://hsgm.saglik.gov.tr/depo/birimler/tuberkuloz_db/dosya/raporlar/Tu_rkiye_de_Verem_Savas_2018_Raporu_kapakl_.pdf adresinden 12 Nisan 2020 tarihinde erişildi.
  • 3. Cruz AT, Starke JR. Pediatric tuberculosis. Pediatr Rev 2010; 31(1): 13-25.
  • 4. Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res 2012; 135(5): 703–730.
  • 5. Contwell M, Shebab Z, Costello A et al. Epidemiology of tuberculosis in the United States, 1985 through 1992, Jama 1994; 272: 535-539.
  • 6. Taşkesen M, Taş MA, Ecer S, ve ark. Tüberküloz Menenjitli Çocuklarda Kranial Tomografi ve Kranial Magnetik Rezonans Bulgularının İrdelenmesi. Dicle Tıp Dergisi 2005; 32: 117-122.
  • 7. Yaramış A, Gürkan F, Elevli M et al. Central Nervous System Tuberculosis in Children: A Review of 214 Cases. Pediatrics 1998; 102: 49-59.
  • 8. Farinha NJ, Razali KA, Holzel H, et al. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 2000; 41(1): 61-68.
  • 9. Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21(2): 243–261.
  • 10. Thilothammal N, Krishnamurthy PV, Runyan DK, et al. Does BCG vaccine prevent tuberculous meningitis? Arch Dis Child 1996; 74(2): 144-147.
  • 11. Bahr NC, Marais S, Caws M, et al. GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last. Clin Infect Dis Off Publ Infect Dis Soc Am 2016; 62(9):1133–1135.
  • 12. Nhu NTQ, Heemskerk D, Thu DDA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 2014; 52(1): 226–233.
  • 13. Cherry J, Demmler-Harrison G, Kaplan S, et al. Textbook of Pediatric Infectious Diseases, 7th ed. Saunders, Philadelphia, 2014.
  • 14. Bozdemir ŞE, Çelebi S, Hacımustafaoğlu M, ve ark. Tüberküloz menenjitli olguların değerlendirilmesi. J Pediatr Inf 2011; 5: 91-95.
  • 15. Garg RK, Malhotra HS, Jain A. Neuroimaging in tuberculous meningitis. Neurol India 2016; 64(2): 219–227.
  • 16. Uysal G, Köse G, Güven A, et al. Magnetic Resonance Imaging in Diagnosis of Childhood Central Nervous System Tuberculosis. Infection 2001; 29(3): 148–153.
  • 17. Lammie GA, Hewlett RH, Schoeman JF, et al. Tuberculous cerebrovascular disease: a review. J Inf Secur 2009; 59: 156–166.
  • 18. Misra UK, Kumar M, Kalita J. Seizures in tuberculous meningitis. Epilepsy Res 2018;148: 90-95.
  • 19. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.

A Case of Childhood Central Nervous System Tuberculosis with Concomitant Cerebral Infarction

Year 2020, Volume: 4 Issue: 1, 51 - 55, 30.04.2020
https://doi.org/10.34084/bshr.719006

Abstract

Although central nervous system tuberculosis is very rare in children, it is the most common cause of tuberculosis-related death and long-term sequela. The BCG vaccine is known to protect patients with high rates of tuberculosis meningitis, but its protection decreases with age. The pathogen of the disease can not always be proven, the diagnosis can only made by the evaluation of the story, physical examination, laboratory and imaging methods together. The prognosis of the disease is directly related to early diagnosis and the time of initiation of anti-tuberculosis treatment. Central nervous system tuberculosis case with cerebral infarction is presented for the purpose of emphasizing early diagnosis and treatment.

References

  • 1. Zumla A, George A, Sharma V, et al. The WHO 2014 global tuberculosis report–further to go. Lancet Glob Health 2015; 3(1): e10–2.
  • 2. Türkiyede Verem Savaş Raporu 2018. https://hsgm.saglik.gov.tr/depo/birimler/tuberkuloz_db/dosya/raporlar/Tu_rkiye_de_Verem_Savas_2018_Raporu_kapakl_.pdf adresinden 12 Nisan 2020 tarihinde erişildi.
  • 3. Cruz AT, Starke JR. Pediatric tuberculosis. Pediatr Rev 2010; 31(1): 13-25.
  • 4. Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis & treatment of miliary tuberculosis. Indian J Med Res 2012; 135(5): 703–730.
  • 5. Contwell M, Shebab Z, Costello A et al. Epidemiology of tuberculosis in the United States, 1985 through 1992, Jama 1994; 272: 535-539.
  • 6. Taşkesen M, Taş MA, Ecer S, ve ark. Tüberküloz Menenjitli Çocuklarda Kranial Tomografi ve Kranial Magnetik Rezonans Bulgularının İrdelenmesi. Dicle Tıp Dergisi 2005; 32: 117-122.
  • 7. Yaramış A, Gürkan F, Elevli M et al. Central Nervous System Tuberculosis in Children: A Review of 214 Cases. Pediatrics 1998; 102: 49-59.
  • 8. Farinha NJ, Razali KA, Holzel H, et al. Tuberculosis of the central nervous system in children: a 20-year survey. J Infect 2000; 41(1): 61-68.
  • 9. Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21(2): 243–261.
  • 10. Thilothammal N, Krishnamurthy PV, Runyan DK, et al. Does BCG vaccine prevent tuberculous meningitis? Arch Dis Child 1996; 74(2): 144-147.
  • 11. Bahr NC, Marais S, Caws M, et al. GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last. Clin Infect Dis Off Publ Infect Dis Soc Am 2016; 62(9):1133–1135.
  • 12. Nhu NTQ, Heemskerk D, Thu DDA, et al. Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis. J Clin Microbiol 2014; 52(1): 226–233.
  • 13. Cherry J, Demmler-Harrison G, Kaplan S, et al. Textbook of Pediatric Infectious Diseases, 7th ed. Saunders, Philadelphia, 2014.
  • 14. Bozdemir ŞE, Çelebi S, Hacımustafaoğlu M, ve ark. Tüberküloz menenjitli olguların değerlendirilmesi. J Pediatr Inf 2011; 5: 91-95.
  • 15. Garg RK, Malhotra HS, Jain A. Neuroimaging in tuberculous meningitis. Neurol India 2016; 64(2): 219–227.
  • 16. Uysal G, Köse G, Güven A, et al. Magnetic Resonance Imaging in Diagnosis of Childhood Central Nervous System Tuberculosis. Infection 2001; 29(3): 148–153.
  • 17. Lammie GA, Hewlett RH, Schoeman JF, et al. Tuberculous cerebrovascular disease: a review. J Inf Secur 2009; 59: 156–166.
  • 18. Misra UK, Kumar M, Kalita J. Seizures in tuberculous meningitis. Epilepsy Res 2018;148: 90-95.
  • 19. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/ Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
There are 19 citations in total.

Details

Primary Language Turkish
Subjects Infectious Diseases
Journal Section Case Report
Authors

Bahri Elmas 0000-0001-9034-6109

Onur Bircan 0000-0002-0920-7652

Pınar Dervişoğlu 0000-0001-5726-0362

Mehmet Fatih Orhan 0000-0001-8081-6760

Didem Altunsoy This is me 0000-0003-1164-7662

Muhterem Duyu 0000-0001-7892-2927

Publication Date April 30, 2020
Acceptance Date April 19, 2020
Published in Issue Year 2020 Volume: 4 Issue: 1

Cite

AMA Elmas B, Bircan O, Dervişoğlu P, Orhan MF, Altunsoy D, Duyu M. Serebral Enfarktla Seyreden Çocukluk Çağı Santral Sinir Sistemi Tüberkülozu Olgusu. J Biotechnol and Strategic Health Res. April 2020;4(1):51-55. doi:10.34084/bshr.719006

Journal of Biotechnology and Strategic Health Research